Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PAVBLU 40 MG/ML SOLUCION INYECTABLE EN VIAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PAVBLU 40 MG/ML SOLUCION INYECTABLE EN VIAL

Approved

STANDARD

PAVBLU 40 MG/ML SOLUCION INYECTABLE EN VIAL

Amgen Technology (Ireland) Unlimited Company🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 9, 2025
Approval ID: 6037ddee03400c3e
Company: Amgen Technology (Ireland) Unlimited Company
Type: Standard

Approval Details

Approval Id: 6037ddee03400c3e
Drug Cima Aemps Name: PAVBLU 40 MG/ML SOLUCION INYECTABLE EN VIAL
Register Number: 1251909002
Holder Company Name: Amgen Technology (Ireland) Unlimited Company
Marketing Company Name: Amgen S.A.
Holder Company Detail Path: /organization/05eb04f383ac89ae/amgen-technology-ireland-unlimited-company
Marketing Company Detail Path: /organization/93b0962ff9016fb1/amgen-sa
Authorization Date: 2025-04-09
Dosage Form: SOLUCIÓN INYECTABLE
Dose: 40 mg/ml
Route Of Administration: VÍA INTRAVÍTREA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Amgen Technology (Ireland) Unlimited Company
Company Detail Path: /organization/05eb04f383ac89ae/amgen-technology-ireland-unlimited-company

Company Information

Pharmaceutical Company Name: AMGEN TECHNOLOGY (IRELAND) UNLIMITED COMPANY
Country Name: Ireland
City Name: dun laoghaire,country_ie
Address: Pottery Road

Active Ingredients

AFLIBERCEPT

11,10 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 9, 2025

Approval ID

6037ddee03400c3e

Type

Standard

Back to CIMA-AEMPS Approvals